TPG likely to sell 6% stake in Sai Life Sciences at estimated price of Rs 885 crore in block deal: Report

Global assets management company TPG is likely to sell 12.5 million shares representing 6% stake Sai Life Sciences at an estimated deal size of $102 million (Rs 885 crore), according to a report. The base price of the deal is likely at Rs 710 per share which is a discount of 2.5% over the current market price.

There will be a 60-day lock-in period for the seller, a CNBC-TV18 report said, citing sources.

TPG held over 5.15 crore equity shares in the company as on March 31, 2025 through TPG Asia VII SF PTE Ltd, which accounts for a 24.73% stake in this smallcap company. The market capitalisation of the company is at Rs 15,230 crore. The stock of Sai Life Sciences was listed on the exchanges on December 18, 2024.

The stock has declined nearly 4% since its listing and on the year-to-date basis. This is an underperformance versus Nifty which has given returns of 5% and 4%, respectively.

Sai Life Sciences is a contract research, development, and manufacturing organisation (CRDMO) among listed Indian peers. The company has operations in the UK, the USA and Japan.

The company reported a 57% year-on-year profit in its Q4FY25 net profit at Rs 88 crore versus Rs 56 crore reported in the year ago period. The total revenue from operations in the January-March quarter of FY25 stood at Rs 589 crore, which was growth of 33% versus Rs 443 crore posted by the company in the corresponding quarter of the previous financial year.According to Trendlyne data, shares of Sai Life Sciences are trading above its 50-day and 100-day simple moving averages (SMAs) of Rs 726 and Rs 714, respectively.The stock has been quite volatile since the last 3 months. Its 1-year beta is at 1.4.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)